Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 965 páginas
Examen

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 6th Ed Test Bank Chapter-by-Chapter APRN Exam Prep

Document preview thumbnail
Vista previa 4 fuera de 965 páginas

Prepare for advanced pharmacology and APRN examinations with an independently created, chapter-by-chapter Test Bank aligned with Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Teri Moser Woo and Wendy L. Wright. This nursing resource features original practice questions, detailed rationales, clinical judgment, medication safety, evidence-based practice, pharmacotherapeutics, and case-based learning for FNP, AGPCNP, AGACNP, PMHNP, WHNP, and PNP students. Strengthen clinical reasoning and exam readiness with targeted APRN Exam Prep and realistic practice questions. Pharmacotherapeutics for Advanced Practice Nurse Prescribers 6th Edition Test Bank APRN pharmacology practice questions with rationales Advanced practice nurse prescriber exam prep Chapter-by-chapter APRN pharmacology test bank FNP AGPCNP AGACNP PMHNP pharmacology review Graduate nursing pharmacotherapeutics practice questions APRN board exam pharmacology preparation APRN Test Bank, Pharmacotherapeutics Test Bank, Advanced Practice Nurse Prescribers, 6th Edition Test Bank, APRN Pharmacology, Nursing Pharmacology, Advanced Practice Nursing, Nurse Practitioner Exam Prep, APRN Board Review, FNP Pharmacology, AGPCNP Pharmacology, AGACNP Pharmacology, PMHNP Pharmacology, WHNP Pharmacology, PNP Pharmacology, Clinical Judgment Nursing, Medication Safety, Evidence-Based Practice, Pharmacotherapy Practice Questions, Graduate Nursing Exam Prep

Vista previa del contenido

Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition


• Author(s)Teri Moser Woo; Wendy
L. Wright


TEST BANK


▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations

, 1. A newly certified family nurse practitioner is preparing to
prescribe a medication for a patient with a chronic condition.
Before initiating therapy, which action best demonstrates
advanced practice prescribing responsibility?
A. Select the medication most commonly prescribed by colleagues in
the practice
B. Review the patient's diagnosis, current medications, allergies, organ
function, treatment goals, and preferences
C. Choose the medication with the lowest acquisition cost regardless of
clinical factors
D. Prescribe the standard first-line medication without obtaining
additional patient-specific information
Correct Answer: B
Rationale: Safe prescribing requires an individualized assessment that
integrates the diagnosis, patient-specific factors, comorbidities,
allergies, current medications, organ function, goals, and preferences.
Prescribing is a clinical decision-making process rather than simply
selecting a commonly used or guideline-preferred drug. Options A, C,
and D omit essential patient-specific considerations.
2. A nurse practitioner is evaluating whether to prescribe a
medication that carries a boxed warning for a serious adverse
effect. Which approach is most appropriate?
A. Avoid the medication under all circumstances because a boxed
warning is an absolute contraindication
B. Prescribe the medication without discussing the warning because the
patient may become unnecessarily concerned
C. Evaluate the individual benefit-risk profile, assess whether risk-

,mitigation strategies are available, and counsel the patient
appropriately
D. Use the medication only after another prescriber has authorized the
prescription
Correct Answer: C
Rationale: A boxed warning identifies serious risks that require careful
consideration but does not automatically mean the medication is
contraindicated for every patient. The prescriber should assess the
individual benefit-risk balance, identify risk-reduction strategies,
monitor appropriately, and communicate relevant risks and benefits.
Options A, B, and D represent inappropriate oversimplification of the
warning.
3. An APRN is prescribing a medication for a patient who reports
taking several prescription drugs, herbal products, and over-the-
counter medications. Which action should occur first?
A. Prescribe the medication and review interactions at the follow-up
visit
B. Ask the patient to discontinue all nonprescription products
C. Perform a comprehensive medication reconciliation before selecting
therapy
D. Select the medication with the shortest half-life
Correct Answer: C
Rationale: Medication reconciliation is essential before prescribing
because drug-drug, drug-disease, and drug-supplement interactions
may significantly affect medication selection and safety. Automatically
discontinuing all nonprescription products is inappropriate, and
pharmacokinetic characteristics alone should not determine selection.

, 4. A patient asks an APRN why a medication dose must be reduced
because of chronic kidney disease. Which explanation is most
accurate?
A. Reduced kidney function may decrease drug elimination, increasing
exposure and toxicity risk
B. Kidney disease always increases hepatic metabolism of medications
C. Reduced renal function prevents all medications from reaching
therapeutic concentrations
D. Dose reductions are required only for medications administered
intravenously
Correct Answer: A
Rationale: Reduced renal function can decrease elimination of drugs or
active metabolites that depend substantially on renal clearance,
resulting in accumulation and toxicity. Dose adjustment may involve
reducing the dose, extending the dosing interval, or both. Options B, C,
and D are incorrect generalizations.
5. A pregnant patient asks whether she should stop a prescribed
medication immediately after learning she is pregnant. What is
the APRN's best response?
A. “Yes. All prescription medications should be discontinued during
pregnancy.”
B. “No medication can affect the fetus after the first trimester.”
C. “Do not stop it abruptly; we should evaluate the medication's
benefits, risks, alternatives, and the consequences of untreated
disease.”
D. “Pregnancy labeling categories provide a sufficient basis for making
the decision.”
Correct Answer: C

Libro relacionado
 image
Editorial: Desconocido ISBN: 9781719648035 Edición: Desconocido

Información del documento

Subido en
22 de julio de 2026
Número de páginas
965
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$26.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
20
Última venta
-



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes